Diabetes and pancreatic cancer

Journal of the Pancreas

Volumn 12, Issue 4, 2011, Pages 330-333

  Hsu, Christine ^a   Saif, Muhammad Wasif ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Diabetes mellitus; Metformin; Pancreatic neoplasms; Type 1; Type 2

Indexed keywords

METFORMIN;

ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS CANCER; SURVIVAL TIME;

ADENOCARCINOMA; CHICAGO; CONGRESSES AS TOPIC; DIABETES MELLITUS; HUMANS; ILLINOIS; MEDICAL ONCOLOGY; PANCREATIC NEOPLASMS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 79960214757     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Krejs GJ. Pancreatic cancer: epidemiology and risk factors. Dig Dis 2010;28(2):355-8.
2. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999 Jul;189(1):1-7.
3. DiMagno EP. Pancreatic cancer: clinical presentation, pitfalls and early clues. Ann Oncol 1999;10Suppl 4:S140-2.
4. Permert J, Larsson J, Westermark GT, et al. Islet amyloid polypeptide in patientswith pancreatic cancer and diabetes. N Engl J Med 1994; 330:313-8.
5. Schwarts SS, Zeidler A, Moossa AR et al. A prospective study of glucoseintolerance, insulin, C-peptide, and glucagon in patients with pancreaticcarcinoma. Am J Dig Dis 1978; 23: 1107-14.
6. Chari ST, Leibson CL, Rabe KG, et al. Pancreatic cancerassociated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008;134:95-101.
7. Gullo, L. Diabetes and risk of pancreatic cancer. Ann Oncol 1999;10Suppl 4 S79-81.
8. Gullo L, Pezzilli R, Morselli-Labate AM. Italian Pancreatic Cancer Study Group: Diabetes and the risk of pancreatic cancer. N Engl J Med 1994; 331:81-4.
9. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995; 273(20):1605-9.
10. Stevens RJ, Roddam AW, Beral V. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer 2007;96(3):507-509.
11. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, Zhang H, Li Z. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. European Journal of Cancer. March 2011; 1-7.
12. Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005;92(11):2076-2083.
13. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293(2):194-202.
14. Bailey CJ, Turner RC. Drug therapy: metformin. N Engl J Med 1996; 334:574-9.
15. Schneider MB, Matsuzaki H, Haorah J, et al. Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 2001; 120:1263-70.
16. Lee MS, Hsu CC, Wahlqvist M, Tsai HN, Chang, YH, Huang YC. Type 2 diabetes increases and metformin reduces total, colorectal, liver, and pancreatic incidences in Taiwanese: A representative population prospective cohort study of 800,000 individuals. BMC Cancer 2011; 11:20: 1-10.
17. Yacoub A, Siegel E, Makhoul E. Pancreatic cancer and diabetes mellitus: A retrospective cohort study. J Clin Oncol 2011; 29(Suppl.):4102.
18. Sadeghi N, Abbruzzese JL, Yeung SJ, Hassan M, Li D. Effect of metformin on survival of diabetic patients with pancreatic adenocarcinoma. J Clin Oncol 2011; 29(Suppl.):4063.
19. Kisfalvi K, Eibl G, Sinnett-Smith J, Rozengurt E. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res 2009;69:6539-45.